Financial Management Professionals’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5K | Sell |
20
-14
| -41% | -$7.35K | ﹤0.01% | 536 |
|
|
2025
Q1 | $21.6K | Sell |
34
-1
| -3% | -$634 | ﹤0.01% | 414 |
|
|
2024
Q4 | $24.9K | Sell |
35
-1
| -3% | -$712 | ﹤0.01% | 370 |
|
|
2024
Q3 | $38K | Hold |
36
| – | – | ﹤0.01% | 303 |
|
|
2024
Q2 | $38K | Sell |
36
-82
| -69% | -$86.6K | 0.01% | 296 |
|
|
2024
Q1 | $114K | Sell |
118
-5
| -4% | -$4.83K | 0.02% | 189 |
|
|
2023
Q4 | $108K | Sell |
123
-2
| -2% | -$1.76K | 0.02% | 178 |
|
|
2023
Q3 | $103K | Buy |
125
+8
| +7% | +$6.59K | 0.02% | 172 |
|
|
2023
Q2 | $84K | Buy |
117
+1
| +0.9% | +$718 | 0.01% | 208 |
|
|
2023
Q1 | $95K | Buy |
116
+85
| +274% | +$69.6K | 0.02% | 210 |
|
|
2022
Q4 | $22K | Hold |
31
| – | – | ﹤0.01% | 353 |
|
|
2022
Q3 | $21K | Buy |
31
+17
| +121% | +$11.5K | ﹤0.01% | 346 |
|
|
2022
Q2 | $8K | Hold |
14
| – | – | ﹤0.01% | 541 |
|
|
2022
Q1 | $10K | Buy |
14
+1
| +8% | +$714 | ﹤0.01% | 530 |
|
|
2021
Q4 | $8K | Hold |
13
| – | – | ﹤0.01% | 524 |
|
|
2021
Q3 | $8K | Hold |
13
| – | – | ﹤0.01% | 521 |
|
|
2021
Q2 | $7K | Buy |
13
+8
| +160% | +$4.31K | ﹤0.01% | 465 |
|
|
2021
Q1 | $2K | Sell |
5
-1
| -17% | -$400 | ﹤0.01% | 591 |
|
|
2020
Q4 | $3K | Buy |
6
+3
| +100% | +$1.5K | ﹤0.01% | 507 |
|
|
2020
Q3 | $2K | Hold |
3
| – | – | ﹤0.01% | 526 |
|
|
2020
Q2 | $2K | Buy |
+3
| New | +$2K | ﹤0.01% | 514 |
|